Real-time enrollment status for this relapse multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:08 PM UTC
| NCT Number | NCT07479979 |
| Recruiting Status | Recruiting |
| Condition | Relapse Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 62 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Natalie Callander |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 16, 2026: Clinical trial NCT07479979 is currently recruiting participants. This phase1 study for relapse multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Natalie Callander. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07479979 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07479979 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.